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NOTES A N D  LETTERS 
Pancreatitis Associated 
with Valproic Acid 
Therapy for Epilepsy 
David L. Coulter, MD, and Richard J. Allen, M D  
Valproic acid is useful for absence, myoclonic, and grand 
ma1 seizures and adjunctively for mixed seizures [31. The 
drug has been well tolerated in most patients, but vomiting, 
rashes, hair loss, leukopenia, and thrombocytopenia have 
been observed. Seven patients have developed hepatitis, 
which was fatal in 6 151. We recently treated a child who 
developed pancreatitis in direct association with valproic 
acid therapy. 
An 8-year-old boy with myoclonic and akinetic seizures 
was taking phenytoin, 150 mg per day (6.4 mglkglday), val- 
proic acid, 1,500 mg per day (64.4 mglkglday), and 
clonazepam, 1.5 mg per day (0.06 mglkglday). Intermittent 
vomiting developed and the serum glutamic oxaloacetic 
transaminase (SGOT) level rose to twice normal. At 8Y2 
years of age, in February, 1979, he was hospitalized with 
lethargy, vomiting, and abdominal pain. 
He was afebrile and normotensive. A maculopapular 
rash was present. The abdomen was tense and bowel 
sounds were decreased. He was lethargic, and there was a 
right-sided Babinski sign. Laboratory data included cal- 
cium, 8.9 mEq/L; white blood cell count, 39,000; SGOT 
and serum glutamic pyruvic transaminase, twice normal 
levels; and amylase, 1,125 Somogyi units (normal, less than 
150 units). The phenytoin level was 4.4 pglml and valproic 
acid, 72 pg/ml. A urine drug screen was negative. 
Phenytoin was continued intravenously but valproic acid 
and clonazepam were discontinued. Abdominal ultrasound 
examination showed diffuse pancreatic enlargement with 
no fluid collection and normal gallbladder and liver. 
Mumps titer was less than 1 : 8. A left thoracentesis yielded 
80 ml of serous fluid with an amylase level of 4,000 units. 
Over the next three days the abdomen became less tense 
and the serum amylase fell to 135 units. He was discharged 
asymptomatic on the twelfth hospital day, taking only phe- 
nytoin, 200 mg per day. When seizures recurred, valproic 
acid was restarted and cautiously increased to 500 mg per 
day. Blood counts, SGOT, and repeated amylase levels 
were normal and the electroencephalogram was much im- 
proved. 
Three months later he again developed recurrent vom- 
iting and abdominal pain. He was afebrile and normoten- 
sive. The abdomen was soft and bowel sounds were nor- 
mal, but there was moderate tenderness and guarding. 
White blood cell count was 17,100 and serum amylase 
level, 2,000 units. Phenytoin was continued intravenously 
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and valproic acid was discontinued. By the fifth hospital 
day, amylase was 269 units. Abdominal ultrasound on the 
seventh day showed a normal pancreas, and an oral 
cholecystogram was normal. Seizures were subsequently 
controlled with phenytoin and phenobarbital. H e  was dis- 
charged asymptomatic on the ninth hospital day with a 
normal amylase level and four months later was still well. 
Drugs associated with pancreatitis include thiazide di- 
uretics, furosemide, ethacrynic acid, chlorthalidone, 
acetaminophen, phenformin, propoxyphene, clonidine, 
tetracycline, rifampin, azathioprine, asparaginase, oral 
contraceptives, corticosteroids, and adrenocorticotropic 
hormone [la]. The patient reported here had taken none of 
these drugs, and a urine drug screen was negative. Other 
common causes of pancreatitis include cholelithiasis, 
trauma, surgery, mumps, hyperparathyroidism, hyper- 
lipidemia, aminoaciduria, hemochromatosis, and alco- 
holism [4]. Most of these diseases are rare in children 
and were excluded in our patient. 
Our  patient recovered from the first episode of pan- 
creatitis while taking phenytoin alone, suggesting that this 
drug was not the cause of his illness. Three months later, 
reinitiation of valproic acid was associated with a recur- 
rence of pancreatitis. The second episode also cleared 
while he was taking phenytoin but without valproic acid. 
The present evidence suggests that pancreatitis was asso- 
ciated with the use of valproic acid. We have measured 
serum amylase levels in more than 20 additional children 
taking valproic acid in conjunction with other anticonvul- 
sants and have discovered no elevations thus far, suggesting 
that this must be an unusual complication of valproic acid 
therapy. However, 3 other patients have recently been 
reported who developed pancreatitis from valproic acid 
[ I ,  21. 
Addendum 
Since we submitted this report, a 10-year-old girl from our 
clinic, treated with valproic acid alone at 30 mg per kilo- 
gram per day for three months, developed recurrent vom- 
iting with an elevated serum amylase level. She died 
following laparotomy that demonstrated hemorrhagic 
pancreatitis. 
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